"The U.S. Food and Drug Administration today approved Orbactiv (oritavancin), a new antibacterial drug to treat adults with skin infections.
Orbactiv is approved to treat patients with acute bacterial skin and skin structure infections (ABSS"...
Cetacaine Side Effects Center
Medical Editor: John P. Cunha, DO, FACOEP
Cetacaine Topical Anesthetic (benzocaine, aminobenzoate and tetracaine) is a topical anesthetic used on mucosal membranes to suppress the gag reflex, control pain and ease discomfort during dental and medical procedures. Common side effects include redness, itching, or swelling where the anesthetic was applied.
Cetacaine Spray is applied for approximately one second or less for normal anesthesia. Only a limited quantity of Cetacaine is required for anesthesia. Cetacaine may interact with other drugs. Tell your doctor all medications and supplements you use. Cetacaine should not be used during early pregnancy. Later during pregnancy, Cetacaine should be used only if prescribed. Consult your doctor before breastfeeding.
Our Cetacaine Topical Anesthetic (benzocaine, aminobenzoate and tetracaine) Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
What is Prescribing information?
The FDA package insert formatted in easy-to-find categories for health professionals and clinicians.
Cetacaine FDA Prescribing Information: Side Effects
Hypersensitivity Reactions: Unpredictable adverse reactions (ie, hypersensitivity, including anaphylaxis) are extremely rare.
Localized allergic reactions may occur after prolonged or repeated use of any aminobenzoate anesthetic. The most common adverse reaction caused by local anesthetics is contact dermatitis charaterized by erythema and pruritus that may progress to vesiculation and oozing. This occurs most commonly in patients following prolonged self-medication, which is contraindicated. If rash, urticaria, edema, or other manifestations of allergy develop during use, the drug should be discontinued. To minimize the possibility of a serious allergic reaction, Cetacaine (benzocaine, aminobenzoate and tetracaine) preparations should not be applied for prolonged periods except under continual supervision. Dehydration of the epithelium or an escharotic effect may also result from prolonged contact.
Read the entire FDA prescribing information for Cetacaine (Benzocaine, Aminobenzoate and Tetracaine)
Additional Cetacaine Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.